Agilent Appoints Adam S. Elinoff as Chief Financial Officer
Adam S. Elinoff, Chief Financial Officer, Agilent | Effective November 17, 2025 • Photo Credit: Agilent
Corporate Business News Sponsored by VS News Network
SANTA CLARA, Calif., October 27, 2025 (BUSINESS WATCH GLOBAL) – Biotechnology and life sciences company Agilent Technologies Inc. (NYSE: A) has announced the appointment of Adam S. Elinoff as Chief Financial Officer, effective November 17, 2025.
Elinoff brings nearly 20 years of experience in corporate finance, investor relations, strategy, and business transformation. He joins Agilent from Amgen, where he held several senior finance and strategy positions over a 19-year tenure, most recently serving as Vice President of Finance and Treasurer.
“We are thrilled to welcome Adam to the Agilent team and look forward to partnering with him as we build on our momentum and execute our financial priorities. Adam’s expertise in strategic planning and M&A and his commitment to cross-functional collaboration will be invaluable as we accelerate Agilent’s Ignite Operating System. We are confident his industry experience and leadership will help us deliver even greater innovation and value creation for our customers and shareholders,” said Padraig McDonnell, President and CEO of Agilent.
McDonnell also expressed appreciation for Rodney Gonsalves, who has served as interim CFO. “On behalf of the Agilent Board and management team, I would also like to thank Rodney Gonsalves for his leadership and service as interim chief financial officer. Rodney will continue in his role as corporate controller and principal accounting officer,” he said.
“Agilent is a global leader and powerhouse of innovation in life sciences, diagnostics, and applied markets, and it is a privilege to join as the company’s next CFO—especially at this exciting time for the company. I’m eager to hit the ground running, working closely with Padraig and the rest of the executive team as we build on Agilent’s strong foundation and help accelerate the company’s next chapter of success,” said Elinoff.
Before his most recent role at Amgen, Elinoff served as Regional CFO for Europe, the Middle East, Africa, Latin America, and Canada, based in Switzerland. He oversaw finance and analytics teams across 67 markets and managed a $6 billion profit and loss portfolio. He also helped establish the Amgen Capability Center in Portugal and contributed to regional revenue and profitability growth. Earlier in his career, he held finance leadership roles in corporate financial planning and analysis, business services, and research and development finance.
Prior to joining Amgen, Elinoff held finance leadership roles at Shire Pharmaceuticals and International Rectifier. He began his career as a Peace Corps volunteer in Senegal, where he helped establish microcredit programs for local entrepreneurs.
Elinoff earned a Bachelor of Arts in Economics from Hamilton College and an MBA from Arizona State University’s W. P. Carey School of Business.
Agilent Technologies is a global company specializing in analytical and clinical laboratory technologies that provide instruments, software, and services across scientific and healthcare markets. The company reported $6.51 billion in revenue in fiscal year 2024 and employs approximately 18,000 people worldwide.
For more information, visit www.agilent.com.
Source: Agilent Technologies
